This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
February 23, 2022
Priothera Enters Loan Agreement of €17.5 Million with the European Investment Bank
February 23, 2022
Vicore takes major step towards a clinical platform company targeting AT2R – new molecule ready for phase 1
February 22, 2022
Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2021 Results Presentation and Webcast
February 18, 2022
BONESUPPORT HOLDING AB (PUBL) – PUBLISHES FULL YEAR REPORT 2021
February 17, 2022
Oncopeptides publishes year-end report 2021
February 17, 2022
Targovax ASA: Fourth quarter 2021 results
February 14, 2022
Invitation to presentation of 2021 year-end results
February 10, 2022
BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for year end report 2021
February 10, 2022
Vicore’s AIR study interim analysis suggests that C21 improves lung function in IPF patients
February 09, 2022
Pulmonx to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022